» Articles » PMID: 24448314

Maternal Cardiac Metabolism in Pregnancy

Overview
Journal Cardiovasc Res
Date 2014 Jan 23
PMID 24448314
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnancy causes dramatic physiological changes in the expectant mother. The placenta, mostly foetal in origin, invades maternal uterine tissue early in pregnancy and unleashes a barrage of hormones and other factors. This foetal 'invasion' profoundly reprogrammes maternal physiology, affecting nearly every organ, including the heart and its metabolism. We briefly review here maternal systemic metabolic changes during pregnancy and cardiac metabolism in general. We then discuss changes in cardiac haemodynamic during pregnancy and review what is known about maternal cardiac metabolism during pregnancy. Lastly, we discuss cardiac diseases during pregnancy, including peripartum cardiomyopathy, and the potential contribution of aberrant cardiac metabolism to disease aetiology.

Citing Articles

Roughage Sources During Late Gestation and Lactation Alter Metabolism, Immune Function and Rumen Microbiota in Ewes and Their Offsprings.

Du H, Li K, Guo W, Na M, Zhang J, Na R Microorganisms. 2025; 13(2).

PMID: 40005760 PMC: 11858228. DOI: 10.3390/microorganisms13020394.


The updated understanding of advanced maternal age.

Ye X, Baker P, Tong C Fundam Res. 2024; 4(6):1719-1728.

PMID: 39734537 PMC: 11670706. DOI: 10.1016/j.fmre.2023.09.013.


Gene Analysis of Four Families with Severe Peripartum Cardiomyopathy Reveals Known Gene Mutations and Supports the Recent Call for Screening.

Li M, Yin K, Chen L, Chang J, Hao N Rev Cardiovasc Med. 2024; 25(11):399.

PMID: 39618871 PMC: 11607517. DOI: 10.31083/j.rcm2511399.


The Challenge of Managing Atrial Fibrillation during Pregnancy.

Luca F, Oliva F, Abrignani M, Russo M, Parrini I, Cornara S Rev Cardiovasc Med. 2024; 24(10):279.

PMID: 39077579 PMC: 11273119. DOI: 10.31083/j.rcm2410279.


Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.

Sultan I, Ramste M, Peletier P, Hemanthakumar K, Ramanujam D, Tirronen A Circ Res. 2024; 134(11):1465-1482.

PMID: 38655691 PMC: 11542978. DOI: 10.1161/CIRCRESAHA.123.324136.


References
1.
Kealey A . Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol. 2010; 26(6):185-9. PMC: 2903989. DOI: 10.1016/s0828-282x(10)70397-4. View

2.
Ladner H, Danielsen B, Gilbert W . Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol. 2005; 105(3):480-4. DOI: 10.1097/01.AOG.0000151998.50852.31. View

3.
Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O . Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005; 1(4):259-71. DOI: 10.1016/j.cmet.2005.03.002. View

4.
Halkein J, Tabruyn S, Ricke-Hoch M, Haghikia A, Nguyen N, Scherr M . MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013; 123(5):2143-54. PMC: 3638905. DOI: 10.1172/JCI64365. View

5.
FAIRWEATHER D . Changes in levels of serum non-esterified fatty acid and blood glucose in pregnancy. J Obstet Gynaecol Br Commonw. 1971; 78(8):707-11. DOI: 10.1111/j.1471-0528.1971.tb01633.x. View